Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 751 to 800 of 2422

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Filgotinib for treating moderate to severe rheumatoid arthritisTA676
Brexucabtagene autoleucel for treating relapsed or refractory mantle cell lymphomaTA677
Omalizumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal)TA678
Dapagliflozin for treating chronic heart failure with reduced ejection fractionTA679
Remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn's disease and ulcerative colitisES35
Metreleptin for treating lipodystrophyHST14
Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapyTA673
Pembrolizumab for untreated PD-L1-positive, locally advanced or metastatic urothelial cancer when cisplatin is unsuitable (terminated appraisal)TA674
Vernakalant for the rapid conversion of recent onset atrial fibrillation to sinus rhythm (terminated appraisal)TA675
moorLDLS-BI for burn depth assessmentMIB251
The STAK tool for preventing and treating knee stiffnessMIB252
PROPEL sinus implants for maintaining sinus patency after surgeryMIB253
Trabectedin for the treatment of advanced soft tissue sarcomaTA185
URO17 for detecting bladder cancerMIB250
Mepolizumab for treating severe eosinophilic asthmaTA671
Brolucizumab for treating wet age-related macular degenerationTA672
Leukomed Sorbact for preventing surgical site infectionMTG55
DOAC Dipstick for detecting direct oral anticoagulantsMIB248
CytoSorb for reducing risk of bleeding during cardiac surgeryMIB249
Brain tumours (primary) and brain metastases in over 16sNG99
Brigatinib for ALK-positive advanced non-small-cell lung cancer that has not been previously treated with an ALK inhibitorTA670
Self-expanding implant insertion into the intersphincteric space for faecal incontinenceIPG685
Minimally invasive radical hysterectomy for early stage cervical cancerIPG686
The VAC Veraflo Therapy system for acute infected or chronic wounds that are failing to healMTG54
Accuro for guiding epidural or spinal anaesthesiaMIB245
AcQMap for mapping the heart atria to target ablation treatment for arrhythmiasMIB246
Abortion careQS199
Natural Cycles for monitoring fertilityMIB244
Suspected neurological conditions: recognition and referralQS198
Encorafenib plus cetuximab for previously treated BRAF V600E mutation-positive metastatic colorectal cancerTA668
The PLASMA system for transurethral resection and haemostasis of the prostateMTG53
Antimicrobial prescribing: delafloxacin for acute bacterial skin and skin structure infectionsES32
Optilume for anterior urethral stricturesMIB241
Artificial intelligence in mammographyMIB242
Artificial intelligence for analysing chest CT imagesMIB243
Atezolizumab with bevacizumab for treating advanced or unresectable hepatocellular carcinomaTA666
Caplacizumab with plasma exchange and immunosuppression for treating acute acquired thrombotic thrombocytopenic purpuraTA667
PancreatitisNG104
Diabetes in pregnancy: management from preconception to the postnatal periodNG3
Eating disorders: recognition and treatmentNG69
ReStore Soft Exo-Suit for gait rehabilitationMIB239
Cytosponge for detecting abnormal cells in the oesophagusMIB240
Peripheral arterial disease: diagnosis and managementCG147
Low back pain and sciatica in over 16s: assessment and managementNG59
Venetoclax with obinutuzumab for untreated chronic lymphocytic leukaemiaTA663
Liraglutide for managing overweight and obesityTA664
Upadacitinib for treating severe rheumatoid arthritisTA665
Evoke Spinal Cord Stimulator for managing chronic neuropathic or ischaemic painMIB238
Zio XT for detecting cardiac arrhythmiasMTG52
Darolutamide with androgen deprivation therapy for treating hormone-relapsed non-metastatic prostate cancerTA660

Results per page

  1. 10
  2. 25
  3. 50
  4. All